Telix Pharmaceuticals (innovations) Pty Limited

This early-stage study is testing the safety of a radioactive drug called 131I-TLX101 when added to standard treatment for newly diagnosed glioblastoma, an aggressive brain cancer. Researchers will give increasing doses to 12 patients who have recently had surgery but haven't sta…

This global Phase 3 trial is testing whether adding a new targeted radiation therapy (TLX101-Tx) to standard chemotherapy (lomustine) works better than chemotherapy alone for adults whose aggressive brain cancer (glioblastoma) has returned for the first time. The new therapy aims…

This study is testing if a new type of imaging scan, which combines two technologies (PSMA PET and MRI), is better at finding prostate cancer than the current standard of care. It will enroll 204 men who have never had a prostate biopsy but are suspected of having cancer based on…

This early-stage study is testing a single dose of an experimental radiation drug called TLX090-Tx for patients with advanced cancer who have painful bone metastases. The main goals are to check the treatment's safety, how it moves through the body, and to see if it helps reduce …